Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Johnson & Johnson (JNJ) vs The Travelers Companies Inc. Common Stock (TRV) Price & Performance

Johnson & JohnsonTrade
The Travelers Companies Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Johnson & Johnson vs The Travelers Companies Inc. Common Stock — how do they compare? Johnson & Johnson trades at $255.65 (market cap $618.09B), while The Travelers Companies Inc. Common Stock trades at $368.75 (market cap $77.23B). The key difference: Johnson & Johnson is far larger — about 8× The Travelers Companies Inc. Common Stock's market cap, and Johnson & Johnson pays the higher dividend (2.09%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and The Travelers Companies Inc. Common Stock for 0 Days on average.

JNJTRV
Market Cap
$618.09B$77.23B
Volume
6,050,9831,078,682
Sector
HealthFinancials
52-Week High
$278.43$397.22
52-Week Low
$186.00$261.57
Typical Hold Time
129 Days0 Days
Enterprise Value
$646.37B$85.82B
Dividend Yield
2.09%1.35%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $258.45, up 1.44% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and robust cash flow. Analyst consensus is bullish with a $286.53 price target, though technical indicators show resistance near $260. Recent news highlights pipeline strength including Icotyde's potential $4.5B peak sales.

JNJ offers stable dividend income and pharmaceutical innovation upside, but faces patent cliff risks and competitive pressures. The stock presents value near current levels with 10.7% upside to consensus target, though technical weakness suggests potential near-term consolidation. Long-term growth drivers include oncology portfolio and Ottava surgical system development.

The Travelers Companies Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JNJ
96% Buy4% Sell
Avg holding period · 129 Days
TRV
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Read more on JNJ →

About The Travelers Companies Inc. Common Stock

The Travelers Companies provides property and casualty insurance for individuals, businesses, and organizations. Its products include auto, home, and commercial coverage.

Read more on TRV →